Free Trial
NASDAQ:HSTO

Histogen (HSTO) Stock Price, News & Analysis

Histogen logo
$0.0003 0.00 (0.00%)
As of 07/11/2025

About Histogen Stock (NASDAQ:HSTO)

Key Stats

Today's Range
$0.0003
$0.0003
50-Day Range
$0.00
$0.03
52-Week Range
$0.05
$0.55
Volume
226 shs
Average Volume
10,369 shs
Market Capitalization
$1.28 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive HSTO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Histogen and its competitors with MarketBeat's FREE daily newsletter.

HSTO Stock News Headlines

Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve suffered financial hardship…Our President may have solved everything.
Histogen Files For Voluntary Chapter 11 Bankruptcy Protection
See More Headlines

HSTO Stock Analysis - Frequently Asked Questions

Histogen's stock was trading at $0.0250 at the start of the year. Since then, HSTO shares have decreased by 98.8% and is now trading at $0.0003.

Histogen Inc. (NASDAQ:HSTO) issued its quarterly earnings results on Wednesday, November, 10th. The company reported ($1.80) EPS for the quarter, beating the consensus estimate of ($2.20) by $0.40. The company had revenue of $0.59 million for the quarter.

Histogen's stock reverse split before market open on Friday, June 3rd 2022.The 1-20 reverse split was announced on Friday, June 3rd 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, June 3rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of HSTO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Histogen investors own include Tesla (TSLA), Bionano Genomics (BNGO), Applied Genetic Technologies (AGTC), HubSpot (HUBS), Meta Platforms (META) and TherapeuticsMD (TXMD).

Company Calendar

Last Earnings
11/10/2021
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:HSTO
CIK
1383701
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$19 thousand
Price / Sales
0.07
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.13 per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
4,270,000
Free Float
N/A
Market Cap
$1.28 thousand
Optionable
Not Optionable
Beta
1.19
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:HSTO) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners